 |
PDBsum entry 146d
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
Biochemistry
32:6588-6604
(1993)
|
|
PubMed id:
|
|
|
|
|
| |
|
Solution structure of the mithramycin dimer-DNA complex.
|
|
M.Sastry,
D.J.Patel.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
We have characterized the NMR parameters for the complexes formed by the
Mg(2+)-coordinated mithramycin dimer with self-complementary d(T-G-G-C-C-A) and
d(T-C-G-C-G-A) duplexes. The solution structure of the latter complex has been
determined using a combined NMR-molecular dynamics study including relaxation
matrix refinement. The Mg(2+)-coordinated mithramycin dimer-d(T-C-G-C-G-A)
complex exhibits a 2-fold center of symmetry with the divalent cation
coordinated aglycons positioned opposite the central (G3-C4).(G3-C4) segment
such that the aglycon C8 hydroxyl oxygens form symmetrical sequence-specific
hydrogen bonds to guanine amino protons in the complex. The C-D-E trisaccharide
segments of each monomer in the mithramycin dimer adopt extended conformations,
are positioned inside the minor groove, and are directed toward either end of
the duplex. The C-D saccharide component of one monomer and the aglycon of the
other monomer in the mithramycin dimer share a widened minor groove with the
hydrophobic edges of the C and D sugars interacting with individual strands of
the duplex. The E-sugar ring is positioned in the floor of the minor groove, and
its hydroxyl-bearing face interacts with both strands of the duplex through
hydrogen-bonding and hydrophobic intermolecular interactions. The A-B
disaccharide and the hydrophilic side chain form intermolecular contacts with
the sugar-phosphate backbone in the complex. The antiparallel alignment of
divalent cation coordinated monomers in the mithramycin dimer results in the two
outwardly directed C-D-E trisaccharide segments generating a right-handed
continuous hexasaccharide domain that spans six base pairs in the minor groove
of the duplex. The solution structure of the mithramycin dimer-DNA complex
reported in this study and the solution structure of the chromomycin dimer-DNA
complex reported previously [Gao, X., Mirau, P., & Patel, D. J. (1992) J.
Mol. Biol. 223, 259-279] show global similarities, as well as local differences
that are of interest. All four nucleotides in the tetranucleotide segment of the
duplex centered about the sequence-specific (G-C).(G-C) step adopt A-DNA sugar
puckers and glycosidic torsion angles in the chromomycin dimer-DNA complex,
while only the central cytidine adopts an A-DNA sugar pucker and glycosidic
torsion angle in the mithramycin dimer-DNA complex.(ABSTRACT TRUNCATED AT 400
WORDS)
|
|
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
B.García,
J.González-Sabín,
N.Menéndez,
A.F.Braña,
L.E.Núñez,
F.Morís,
J.A.Salas,
and
C.Méndez
(2011).
The chromomycin CmmA acetyltransferase: a membrane-bound enzyme as a tool for increasing structural diversity of the antitumour mithramycin.
|
| |
Microb Biotechnol,
4,
226-238.
|
 |
|
|
|
|
 |
J.Tan,
L.Zhu,
and
B.Wang
(2010).
From GC-rich DNA binding to the repression of survivin gene for quercetin nickel (II) complex: implications for cancer therapy.
|
| |
Biometals,
23,
1075-1084.
|
 |
|
|
|
|
 |
M.P.Beam,
M.A.Bosserman,
N.Noinaj,
M.Wehenkel,
and
J.Rohr
(2009).
Crystal structure of Baeyer-Villiger monooxygenase MtmOIV, the key enzyme of the mithramycin biosynthetic pathway .
|
| |
Biochemistry,
48,
4476-4487.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
D.J.Bridewell,
A.C.Porter,
G.J.Finlay,
and
B.C.Baguley
(2008).
The role of topoisomerases and RNA transcription in the action of the antitumour benzonaphthyridine derivative SN 28049.
|
| |
Cancer Chemother Pharmacol,
62,
753-762.
|
 |
|
|
|
|
 |
I.Baig,
M.Perez,
A.F.Braña,
R.Gomathinayagam,
C.Damodaran,
J.A.Salas,
C.Méndez,
and
J.Rohr
(2008).
Mithramycin analogues generated by combinatorial biosynthesis show improved bioactivity.
|
| |
J Nat Prod,
71,
199-207.
|
 |
|
|
|
|
 |
M.Pérez,
I.Baig,
A.F.Braña,
J.A.Salas,
J.Rohr,
and
C.Méndez
(2008).
Generation of new derivatives of the antitumor antibiotic mithramycin by altering the glycosylation pattern through combinatorial biosynthesis.
|
| |
Chembiochem,
9,
2295-2304.
|
 |
|
|
|
|
 |
R.Pragani,
and
W.R.Roush
(2008).
Studies on the synthesis of durhamycin A: stereoselective synthesis of a model aglycone.
|
| |
Org Lett,
10,
4613-4616.
|
 |
|
|
|
|
 |
F.Barceló,
C.Scotta,
M.Ortiz-Lombardía,
C.Méndez,
J.A.Salas,
and
J.Portugal
(2007).
Entropically-driven binding of mithramycin in the minor groove of C/G-rich DNA sequences.
|
| |
Nucleic Acids Res,
35,
2215-2226.
|
 |
|
|
|
|
 |
D.Nichol,
M.Christian,
J.H.Steel,
R.White,
and
M.G.Parker
(2006).
RIP140 expression is stimulated by estrogen-related receptor alpha during adipogenesis.
|
| |
J Biol Chem,
281,
32140-32147.
|
 |
|
|
|
|
 |
F.Lombó,
N.Menéndez,
J.A.Salas,
and
C.Méndez
(2006).
The aureolic acid family of antitumor compounds: structure, mode of action, biosynthesis, and novel derivatives.
|
| |
Appl Microbiol Biotechnol,
73,
1.
|
 |
|
|
|
|
 |
V.Albertini,
A.Jain,
S.Vignati,
S.Napoli,
A.Rinaldi,
I.Kwee,
M.Nur-e-Alam,
J.Bergant,
F.Bertoni,
G.M.Carbone,
J.Rohr,
and
C.V.Catapano
(2006).
Novel GC-rich DNA-binding compound produced by a genetically engineered mutant of the mithramycin producer Streptomyces argillaceus exhibits improved transcriptional repressor activity: implications for cancer therapy.
|
| |
Nucleic Acids Res,
34,
1721-1734.
|
 |
|
|
|
|
 |
M.H.Hou,
and
A.H.Wang
(2005).
Mithramycin forms a stable dimeric complex by chelating with Fe(II): DNA-interacting characteristics, cellular permeation and cytotoxicity.
|
| |
Nucleic Acids Res,
33,
1352-1361.
|
 |
|
|
|
|
 |
M.Nur-e-Alam,
C.Méndez,
J.A.Salas,
and
J.Rohr
(2005).
Elucidation of the glycosylation sequence of mithramycin biosynthesis: isolation of 3A-deolivosylpremithramycin B and its conversion to premithramycin B by glycosyltransferase MtmGII.
|
| |
Chembiochem,
6,
632-636.
|
 |
|
|
|
|
 |
S.Das,
P.G.Devi,
S.Pal,
and
D.Dasgupta
(2005).
Effect of complex formation between Zn2+ ions and the anticancer drug mithramycin upon enzymatic activity of zinc(II)-dependent alcohol dehydrogenase.
|
| |
J Biol Inorg Chem,
10,
25-32.
|
 |
|
|
|
|
 |
D.Rodríguez,
L.M.Quirós,
and
J.A.Salas
(2004).
MtmMII-mediated C-methylation during biosynthesis of the antitumor drug mithramycin is essential for biological activity and DNA-drug interaction.
|
| |
J Biol Chem,
279,
8149-8158.
|
 |
|
|
|
|
 |
M.H.Hou,
H.Robinson,
Y.G.Gao,
and
A.H.Wang
(2004).
Crystal structure of the [Mg2+-(chromomycin A3)2]-d(TTGGCCAA)2 complex reveals GGCC binding specificity of the drug dimer chelated by a metal ion.
|
| |
Nucleic Acids Res,
32,
2214-2222.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
D.Rodríguez,
L.M.Quirós,
A.F.Braña,
and
J.A.Salas
(2003).
Purification and characterization of a monooxygenase involved in the biosynthetic pathway of the antitumor drug mithramycin.
|
| |
J Bacteriol,
185,
3962-3965.
|
 |
|
|
|
|
 |
L.J.Ming
(2003).
Structure and function of "metalloantibiotics".
|
| |
Med Res Rev,
23,
697-762.
|
 |
|
|
|
|
 |
N.Vigneswaran,
J.Thayaparan,
J.Knops,
J.Trent,
V.Potaman,
D.M.Miller,
and
W.Zacharias
(2001).
Intra- and intermolecular triplex DNA formation in the murine c-myb proto-oncogene promoter are inhibited by mithramycin.
|
| |
Biol Chem,
382,
329-342.
|
 |
|
|
|
|
 |
M.A.Keniry,
E.A.Owen,
and
R.H.Shafer
(2000).
The three-dimensional structure of the 4:1 mithramycin:d(ACCCGGGT)(2) complex: evidence for an interaction between the E saccharides.
|
| |
Biopolymers,
54,
104-114.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
S.Chakrabarti,
D.Bhattacharyya,
and
D.Dasgupta
(2000).
Structural basis of DNA recognition by anticancer antibiotics, chromomycin A(3), and mithramycin: roles of minor groove width and ligand flexibility.
|
| |
Biopolymers,
56,
85-95.
|
 |
|
|
|
|
 |
L.Prado,
E.Fernández,
U.Weissbach,
G.Blanco,
L.M.Quirós,
A.F.Braña,
C.Méndez,
J.Rohr,
and
J.A.Salas
(1999).
Oxidative cleavage of premithramycin B is one of the last steps in the biosynthesis of the antitumor drug mithramycin.
|
| |
Chem Biol,
6,
19-30.
|
 |
|
|
|
|
 |
E.Fernández,
U.Weissbach,
C.Sánchez Reillo,
A.F.Braña,
C.Méndez,
J.Rohr,
and
J.A.Salas
(1998).
Identification of two genes from Streptomyces argillaceus encoding glycosyltransferases involved in transfer of a disaccharide during biosynthesis of the antitumor drug mithramycin.
|
| |
J Bacteriol,
180,
4929-4937.
|
 |
|
|
|
|
 |
A.C.Weymouth-Wilson
(1997).
The role of carbohydrates in biologically active natural products.
|
| |
Nat Prod Rep,
14,
99.
|
 |
|
|
|
|
 |
S.Majee,
R.Sen,
S.Guha,
D.Bhattacharyya,
and
D.Dasgupta
(1997).
Differential interactions of the Mg2+ complexes of chromomycin A3 and mithramycin with poly(dG-dC) x poly(dC-dG) and poly(dG) x poly(dC).
|
| |
Biochemistry,
36,
2291-2299.
|
 |
|
|
|
|
 |
C.Bailly,
D.Payet,
A.A.Travers,
and
M.J.Waring
(1996).
PCR-based development of DNA substrates containing modified bases: an efficient system for investigating the role of the exocyclic groups in chemical and structural recognition by minor groove binding drugs and proteins.
|
| |
Proc Natl Acad Sci U S A,
93,
13623-13628.
|
 |
|
|
|
|
 |
N.Vigneswaran,
C.A.Mayfield,
B.Rodu,
R.James,
H.G.Kim,
and
D.M.Miller
(1996).
Influence of GC and AT specific DNA minor groove binding drugs on intermolecular triplex formation in the human c-Ki-ras promoter.
|
| |
Biochemistry,
35,
1106-1114.
|
 |
|
|
|
|
 |
C.Bailly,
and
M.J.Waring
(1995).
Transferring the purine 2-amino group from guanines to adenines in DNA changes the sequence-specific binding of antibiotics.
|
| |
Nucleic Acids Res,
23,
885-892.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
code is
shown on the right.
|
');
}
}
 |